Term | 20 Most Highly-Cited Articles Per Term | |
---|---|---|
Full Journal Article Citation | Number of Citations | |
Complementary and Alternative N = 2814 Articles excluded from sample: None | 1. Barnes, P. M., Powell-Griner, E., McFann, K., & Nahin, R. L. (2004). Complementary and alternative medicine use among adults: United States, 2002. In Seminars in Integrative Medicine, 2(2), 54–71. Philadelphia, PA: W.B. Saunders. | 834 |
2. Ernst, E. & Cassileth, B. R. (1998). The prevalence of complementary/alternative medicine in cancer. Cancer, 83(4), 777–782. | 601 | |
3. Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., & Singletary, S. E. (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology, 18(13), 2505–2514. | 591 | |
4. Tindle, H. A., Davis, R. B., Phillips, R. S., & Eisenberg, D. M. (2005). Trends in use of complementary and alternative medicine by US adults: 1997–2002. Alternative Therapies in Health and Medicine, 11(1), 42–49. | 525 | |
5. Kronenberg, F., & Fugh-Berman, A. (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of Internal Medicine, 137(10), 805–813. | 372 | |
6. Molassiotis, A., Fernadez-Ortega, P., Pud, D., Ozden, G., Scott, J. A., Panteli, V., … & Patiraki, E. (2005). Use of complementary and alternative medicine in cancer patients: A European survey. Annals of Oncology, 16(4), 655–663. | 359 | |
7. Barnes, P. M., Bloom, B., & Nahin, R. L. (2008). Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports, (12), 1–23. | 327 | |
8. Boon, H., Stewart, M., Kennard, M. A., Gray, R., Sawka, C., Brown, J. B., … & Haines-Kamka, T. (2000). Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. Journal of Clinical Oncology, 18(13), 2515–2521. | 300 | |
9. Wetzel, M. S., Eisenberg, D. M., & Kaptchuk, T. J. (1998). Courses involving complementary and alternative medicine at US medical schools. Journal of the American Medical Association, 280(9), 784–787. | 292 | |
10. Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: A systematic review. Bulletin of the World Health Organization, 78(2), 258–266. | 285 | |
11. Ni, H., Simile, C., & Hardy, A. M. (2002). Utilization of complementary and alternative medicine by United States adults: Results from the 1999 national health interview survey. Medical Care, 40(4), 353–358. | 283 | |
12. Kessler, R. C., Soukup, J., Davis, R. B., Foster, D. F., Wilkey, S. A., Van Rompay, M. I., & Eisenberg, D. M. (2001). The use of complementary and alternative therapies to treat anxiety and depression in the United States. American Journal of Psychiatry, 158(2), 289–294. | 264 | |
13. Astin, J. A., Marie, A., Pelletier, K. R., Hansen, E., & Haskell, W. L. (1998). A review of the incorporation of complementary and alternative medicine by mainstream physicians. Archives of Internal Medicine, 158(21), 2303–2310. | 246 | |
14. MacLennan, A. H. S. P., Myers, S., & Taylor, A. (2006). The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Medical Journal of Australia, 184(1), 27–31. | 220 | |
15. Xue, C. C., Zhang, A. L., Lin, V., Da Costa, C., & Story, D. F. (2007). Complementary and alternative medicine use in Australia: a national population-based survey. The Journal of Alternative and Complementary Medicine, 13(6), 643–650. | 208 | |
16. Harris, P., & Rees, R. (2000). The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Complementary Therapies in Medicine, 8(2), 88–96. | 202 | |
17. Astin, J. A., Pelletier, K. R., Marie, A., & Haskell, W. L. (2000). Complementary and alternative medicine use among elderly persons: One-year analysis of a Blue Shield Medicare supplement. Journal of Gerontology: Medical Sciences, 55(1), M4-M9. | 188 | |
18. Furnham, A., & Forey, J. (1994). The attitudes, behaviors and beliefs of patients of conventional vs. complementary (alternative) medicine. Journal of Clinical Psychology, 50(3), 458–469. | 172 | |
19. Fairfield, K. M., Eisenberg, D. M., Davis, R. B., Libman, H., & Phillips, R. S. (1998). Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Archives of Internal Medicine, 158(20), 2257–2264. | 162 | |
20. Söllner, W., Maislinger, S., DeVries, A., Steixner, E., Rumpold, G., & Lukas, P. (2000). Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. Cancer, 89(4), 873–880. | 159 | |
Complementary N = 1758 Articles excluded from sample: #16 | 1. Fisher, P., & Ward, A. (1994). Medicine in Europe: Complementary medicine in Europe. British Medical Journal, 309(6947), 107–111. | 495 |
2. Thomas, K. J., Nicholl, J. P., & Coleman, P. (2001). Use and expenditure on complementary medicine in England: A population based survey. Complementary Therapies in Medicine, 9(1), 2–11. | 449 | |
3. Eisenberg, D. M., Kessler, R. C., Van Rompay, M. I., Kaptchuk, T. J., Wilkey, S. A., Appel, S., & Davis, R. B. (2001). Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey. Annals of Internal Medicine, 135(5), 344–351. | 399 | |
4. Ernst, E., & White, A. (2000). The BBC survey of complementary medicine use in the UK. Complementary Therapies in Medicine, 8(1), 32–36. | 303 | |
5. Vincent, C., & Furnham, A. (1996). Why do patients turn to complementary medicine? An empirical study. British Journal of Clinical Psychology, 35(1), 37–48. | 284 | |
6. Downer, S. M., Cody, M. M., McCluskey, P., Wilson, P. D., Arnott, S. J., Lister, T. A., & Slevin, M. L. (1994). Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. British Medical Journal, 309(6947), 86–89. | 249 | |
7. Rao, J. K., Mihaliak, K., Kroenke, K., Bradley, J., Tierney, W. M., & Weinberger, M. (1999). Use of complementary therapies for arthritis among patients of rheumatologists. Annals of Internal Medicine, 131(6), 409–416. | 228 | |
8. Zollman, C., & Vickers, A. (1999). ABC of complementary medicine: What is complementary medicine? British Medical Journal, 319(7211), 693. | 156 | |
9. Paltiel, O., Avitzour, M., Peretz, T., Cherny, N., Kaduri, L., Pfeffer, R. M., … & Soskolne, V. (2001). Determinants of the use of complementary therapies by patients with cancer. Journal of Clinical Oncology, 19(9), 2439–2448. | 146 | |
10. Zollman, C., & Vickers, A. (1999). ABC of complementary medicine: Users and practitioners of complementary medicine. British Medical Journal, 319(7213), 836. | 145 | |
11. Morris, K. T., Johnson, N., Homer, L., & Walts, D. (2000). A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. The American Journal of Surgery, 179(5), 407–411. | 141 | |
12. Goldbeck-Wood, S., Dorozynski, A., Lie, L. G., Yamauchi, M., Zinn, C., Josefson, D., & Ingram, M. (1996). Complementary medicine is booming worldwide. British Medical Journal, 313(7050), 131–133. | 134 | |
13. Sirois, F. M., & Gick, M. L. (2002). An investigation of the health beliefs and motivations of complementary medicine clients. Social Science & Medicine, 55(6), 1025–1037. | 132 | |
14. Sparber, A., Bauer, L., Curt, G., Eisenberg, D., Levin, T., Parks, S., … & Wootton, J. (2000). Use of complementary medicine by adult patients participating in cancer clinical trials. Oncology Nursing Forum, 27(4), 623–630. | 132 | |
15. Pirotta, M. V., Cohen, M. M., Kotsirilos, V., & Farish, S. J. (2000). Complementary therapies: Have they become accepted in general practice? The Medical Journal of Australia, 172(3), 105–109. | 125 | |
16. Vas, J., Méndez, C., Perea-Milla, E., Vega, E., Dolores Panadero, M., León, J. M., … & Jurado, R. (2004). Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: Randomised controlled trial. British Medical Journal, 329(7476), 1216–1220. | 117 | |
17. Ernst, E., Resch, K. L., & White, A. R. (1995). Complementary medicine: What physicians think of it: A meta-analysis. Archives of Internal Medicine, 155(22), 2405–2408. | 116 | |
18. Ernst, E., Rand, J. I., & Stevinson, C. (1998). Complementary therapies for depression: An overview. Archives of General Psychiatry, 55(11), 1026–1032. | 104 | |
19. Fulder, S., & Munro, R. (1985). Complementary medicine in the United Kingdom: Patients, practitioners, and consultations. The Lancet, 326(8454), 542–545. | 104 | |
20. Nam, R. K., Fleshner, N., Rakovitch, E., Klotz, L., Trachtenberg, J., Choo, R., … & Danjoux, C. (1999). Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. The Journal of Urology, 161(5), 1521–1524. | 103 | |
Alternative N = 1708 Articles excluded from sample: #4, 15, 17, 19 | 1. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998). Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. Journal of the American Medical Association, 280(18), 1569–1575. | 4589 |
2. Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of the American Medical Association, 279(19), 1548–1553. | 1729 | |
3. MacLennan, A. H., Wilson, D. H., & Taylor, A. W. (1996). Prevalence and cost of alternative medicine in Australia. The Lancet, 347(9001), 569–573. | 667 | |
4. McNeil, B. J., Pauker, S. G., Sox Jr, H. C., & Tversky, A. (1982). On the elicitation of preferences for alternative therapies. New England Journal of Medicine, 306(21), 1259–1262. | 513 | |
5. Angell, M., & Kassirer, J. P. (1998). Alternative medicine-the risks of untested and unregulated remedies. New England Journal of Medicine, 339(12), 839–841. | 475 | |
6. Burstein, H. J., Gelber, S., Guadagnoli, E., & Weeks, J. C. (1999). Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine, 340(22), 1733–1739. | 441 | |
7. MacLennan, A. H., Wilson, D. H., & Taylor, A. W. (2002). The escalating cost and prevalence of alternative medicine. Preventive Medicine, 35(2), 166–173. | 308 | |
8. Spigelblatt, L., Laîné-Ammara, G., Pless, I. B., & Guyver, A. (1994). The use of alternative medicine by children. Pediatrics, 94(6), 811–814. | 282 | |
9. Lee, M. M., Lin, S. S., Wrensch, M. R., Adler, S. R., & Eisenberg, D. (2000). Alternative therapies used by women with breast cancer in four ethnic populations. Journal of the National Cancer Institute, 92(1), 42–47. | 256 | |
10. Kaptchuk, T. J. (2002). The placebo effect in alternative medicine: Can the performance of a healing ritual have clinical significance? Annals of Internal Medicine, 136(11), 817–825. | 254 | |
11. Heck, A. M., Dewitt, B. A., & Lukes, A. L. (2000). Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy, 57(13), 1221–1227. | 232 | |
12. Paramore, L. C. (1997). Use of alternative therapies: Estimates from the 1994 Robert Wood Johnson Foundation national access to care survey. Journal of Pain and Symptom Management, 13(2), 83–89. | 205 | |
13. Kelner, M., & Wellman, B. (1997). Health care and consumer choice: Medical and alternative therapies. Social Science & Medicine, 45(2), 203–212. | 188 | |
14. Fontanarosa, P. B., & Lundberg, G. D. (1998). Alternative medicine meets science. Journal of the American Medical Association, 280(18), 1618–1619. | 187 | |
15. Das, D. K., & Maulik, N. (2006). Resveratrol in cardioprotection: A therapeutic promise of alternative medicine. Molecular Interventions, 6(1), 36. | 157 | |
16. Newton, K. M., Buist, D. S., Keenan, N. L., Anderson, L. A., & LaCroix, A. Z. (2002). Use of alternative therapies for menopause symptoms: Results of a population-based survey. Obstetrics & Gynecology, 100(1), 18–25. | 150 | |
17. Trenk, D., Stone, G. W., Gawaz, M., Kastrati, A., Angiolillo, D. J., Müller, U., … & Neumann, F. J. (2012). A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. Journal of the American College of Cardiology, 59(24), 2159–2164. | 149 | |
18. Ernst, E., & Pittler, M. H. (1997). Alternative therapy bias. Nature, 385(6616), 480. | 147 | |
19. Meeker, W. C., & Haldeman, S. (2002). Chiropractic: A profession at the crossroads of mainstream and alternative medicine. Annals of Internal Medicine, 136(3), 216–227. | 145 | |
20. Unützer, J., Klap, R., Sturm, R., Young, A. S., Marmon, T., Shatkin, J., & Wells, K. B. (2000). Mental disorders and the use of alternative medicine: Results from a national survey. American Journal of Psychiatry, 157(11). | 144 | |
Integrated/ Integrative N = 455 Articles excluded from sample: #7, 9, 12, 14, 15 | 1. Bell, I. R., Caspi, O., Schwartz, G. E., Grant, K. L., Gaudet, T. W., Rychener, D., … & Weil, A. (2002). Integrative medicine and systemic outcomes research: Issues in the emergence of a new model for primary health care. Archives of Internal Medicine, 162(2), 133–140. | 146 |
2. Kligler, B., Maizes, V., Schachter, S., Park, C. M., Gaudet, T., Benn, R., … & Remen, R. N. (2004). Core competencies in integrative medicine for medical school curricula: A proposal. Academic Medicine, 79(6), 521–531. | 91 | |
3. Snyderman, R., & Weil, A. T. (2002). Integrative medicine: Bringing medicine back to its roots. Archives of Internal Medicine, 162(4), 395–397. | 76 | |
4. Girman, A., Lee, R., & Kligler, B. (2003). An integrative medicine approach to premenstrual syndrome. American Journal of Obstetrics and Gynecology, 188(5), S56-S65. | 51 | |
5. Wang, J., & Xiong, X. (2012). Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine. | 47 | |
6. Xu, H., & Chen, K. (2008). Integrative medicine: The experience from China. The Journal of Alternative and Complementary Medicine, 14(1), 3–7. | 41 | |
7. Scullin, C., Scott, M. G., Hogg, A., & McElnay, J. C. (2007). An innovative approach to integrated medicines management. Journal of Evaluation in Clinical Practice, 13(5), 781–788. | 41 | |
8. Edelman, D., Oddone, E. Z., Liebowitz, R. S., Yancy, W. S., Olsen, M. K., Jeffreys, A. S., … & Gaudet, T. W. (2006). A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine, 21(7), 728–734. | 41 | |
9. Hellström, L. M., Bondesson, Å., Höglund, P., Midlöv, P., Holmdahl, L., Rickhag, E., & Eriksson, T. (2011). Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. European Journal of Clinical Pharmacology, 67(7), 741–752. | 39 | |
10. Maizes, V., Rakel, D., & Niemiec, C. (2009). Integrative medicine and patient-centered care. Explore: The Journal of Science and Healing, 5(5), 277–289. | 39 | |
11. Sundberg, T., Halpin, J., Warenmark, A., & Falkenberg, T. (2007). Towards a model for integrative medicine in Swedish primary care. BMC Health Services Research, 7(1), 107. | 38 | |
12. Kidd, P. M. (2002). Autism, an extreme challenge to integrative medicine. Part 1: The knowledge base. Alternative Medicine Review, 7(4), 292–316. | 38 | |
13. Gaudet, T. W. (1998). Integrative medicine: The evolution of a new approach to medicine and to medical education. Integrative Medicine, 1(2), 67–73. | 38 | |
14. Kidd, P. M. (2002). Autism, an extreme challenge to integrative medicine. Part II: Medical management. Alternative Medicine Review, 7(6), 472–499. | 37 | |
15. Bergkvist, A., Midlöv, P., Höglund, P., Larsson, L., Bondesson, Å., & Eriksson, T. (2009). Improved quality in the hospital discharge summary reduces medication errors—LIMM: Landskrona Integrated Medicines Management. European Journal of Clinical Pharmacology, 65(10), 1037–1046. | 35 | |
16. Hsiao, A. F., Ryan, G. W., Hays, R. D., Coulter, I. D., Andersen, R. M., & Wenger, N. S. (2006). Variations in provider conceptions of integrative medicine. Social Science & Medicine, 62(12), 2973–2987. | 34 | |
17. Weil, A. (2000). The significance of integrative medicine for the future of medical education. American Journal of Medicine, 108(5), 441–443. | 31 | |
18. Lu, A. P., & Chen, K. J. (2009). Integrative medicine in clinical practice: From pattern differentiation in traditional Chinese medicine to disease treatment. Chinese Journal of Integrative Medicine, 15(2), 152–152. | 29 | |
19. Bell, I. R., Cunningham, V., Caspi, O., Meek, P., & Ferro, L. (2004). Development and validation of a new global well-being outcomes rating scale for integrative medicine research. BMC Complementary and Alternative Medicine, 4(1), 1–10. | 29 | |
20. Wang, J., Yao, K., Yang, X., Liu, W., Feng, B., Ma, J., … & Xiong, X. (2012). Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: A systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. | 28 | |
Unconventional N = 103 Articles excluded from sample: None | 1. Eisenberg, D. M., Kessler, R. C., Foster, C., Norlock, F. E., Calkins, D. R., & Delbanco, T. L. (1993). Unconventional medicine in the United States--prevalence, costs, and patterns of use. New England Journal of Medicine, 328(4), 246–252. | 2788 |
2. Druss, B. G., & Rosenheck, R. A. (1999). Association between use of unconventional therapies and conventional medical services. Journal of the American Medical Association, 282(7), 651–656. | 310 | |
3. Kelly, K. M., Jacobson, J. S., Kennedy, D. D., Braudt, S. M., Mallick, M., & Weiner, M. A. (2000). Use of unconventional therapies by children with cancer at an urban medical center. Journal of Pediatric Hematology/Oncology, 22(5), 412–416. | 109 | |
4. Menniti-Ippolito, F., Gargiulo, L., Bologna, E., Forcella, E., & Raschetti, R. (2002). Use of unconventional medicine in Italy: A nation-wide survey. European Journal of Clinical Pharmacology, 58(1), 61–64. | 104 | |
5. Ernst, E. (2003). Serious adverse effects of unconventional therapies for children and adolescents: A systematic review of recent evidence. European Journal of Pediatrics, 162(2), 72–80. | 100 | |
6. Eidinger, R. N., & Schapira, D. V. (1984). Cancer patients' insight into their treatment, prognosis, and unconventional therapies. Cancer, 53(12), 2736–2740. | 88 | |
7. Vickers, A., Cassileth, B., Ernst, E., Fisher, P., Goldman, P., Jonas, W., … & Silagy, C. (1997). How should we research unconventional therapies? A panel report from the Conference on Complementary and Alternative Medicine Research Methodology, National Institutes of Health. International Journal of Technology Assessment in Health Care, 13(1), 111–121. | 77 | |
8. Vickers, A. J., & Cassileth, B. R. (2001). Unconventional therapies for cancer and cancer-related symptoms. The Lancet Oncology, 2(4), 226–232. | 75 | |
9. Nayak, S., Matheis, R. J., Schoenberger, N. E., & Shiflett, S. C. (2003). Use of unconventional therapies by individuals with multiple sclerosis. Clinical Rehabilitation, 17(2), 181–191. | 74 | |
10. Moser, G., Tillinger, W., Sachs, G., Maier-Dobersberger, T., Wyatt, J., Vogelsang, H., … & Gangl, A. (1996). Relationship between the use of unconventional therapies and disease-related concerns: A study of patients with inflammatory bowel disease. Journal of Psychosomatic Research, 40(5), 503–509. | 67 | |
11. Campion, E. W. (1993). Why unconventional medicine? New England Journal of Medicine, 328(4), 282. | 53 | |
12. Dalen, J. E. (1998). Conventional and unconventional medicine: Can they be integrated? Archives of Internal Medicine, 158(20), 2179–2181. | 48 | |
13. Bold, J., & Leis, A. (2001). Unconventional therapy use among children with cancer in Saskatchewan. Journal of Pediatric Oncology Nursing, 18(1), 16–25. | 46 | |
14. Resch, K. I., Ernst, E., & Garrow, J. (2000). A randomized controlled study of reviewer bias against an unconventional therapy. Journal of the Royal Society of Medicine, 93(4), 164–167. | 43 | |
15. Blumberg, D. L., Grant, W. D., Hendricks, S. R., Kamps, C. A., & Dewan, M. J. (1995). The physician and unconventional medicine. Alternative Therapies in Health and Medicine, 1(3), 31–35. | 43 | |
16. Gaus, W., & Hoegel, J. (1995). Studies on the efficacy of unconventional therapies. Problems and designs. Arzneimittel-Forschung, 45(1), 88–92. | 40 | |
17. Lewith, G. T., & Watkins, A. D. (1996). Unconventional therapies in asthma: An overview. Allergy, 51(11), 761–769. | 38 | |
18. Kappauf, H., Leykauf-Ammon, D., Bruntsch, U., Horneber, M., Kaiser, G., Büschel, G., & Gallmeier, W. M. (2000). Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology. Supportive Care in Cancer, 8(4), 314–322. | 37 | |
19. Kaegi, E. (1998). Unconventional therapies for cancer: 1. Essiac. Canadian Medical Association Journal, 158(7), 897–902. | 37 | |
20. Kaegi, E. (1998). Unconventional therapies for cancer: 2. Green tea. Canadian Medical Association Journal, 158(8), 1033. | 33 |